{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:09:33Z","timestamp":1788433773443,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T00:00:00Z","timestamp":1644624000000},"content-version":"vor","delay-in-days":42,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["phiro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physics and Imaging in Radiation Oncology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.phro.2022.02.007","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T13:01:50Z","timestamp":1645102910000},"page":"54-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Inter- and intrafraction motion assessment and accumulated dose quantification of upper gastrointestinal organs during magnetic resonance-guided ablative radiation therapy of pancreas patients"],"prefix":"10.1016","volume":"21","author":[{"given":"Sadegh","family":"Alam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harini","family":"Veeraraghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Tringale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Amoateng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ergys","family":"Subashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Crane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phro.2022.02.007_b0005","first-page":"7","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.phro.2022.02.007_b0010","doi-asserted-by":"crossref","first-page":"439","DOI":"10.6004\/jnccn.2021.0017","article-title":"Pancreatic adenocarcinoma, Version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Tempero","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.phro.2022.02.007_b0015","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1200\/JCO.2012.44.7516","article-title":"Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results","volume":"31","author":"Herman","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.phro.2022.02.007_b0020","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMra0901557","article-title":"Pancreatic cancer","volume":"362","author":"Hidalgo","year":"2010","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.phro.2022.02.007_b0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/jrr\/rrw016","article-title":"Hypofractionated ablative radiotherapy for locally advanced pancreatic cancer","volume":"57","author":"Crane","year":"2016","journal-title":"J Radiat Res"},{"key":"10.1016\/j.phro.2022.02.007_b0030","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1001\/jama.2016.4324","article-title":"Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: the LAP07 randomized clinical trial","volume":"315","author":"Hammel","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.phro.2022.02.007_b0035","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1200\/JCO.2011.34.8904","article-title":"Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial","volume":"29","author":"Loehrer","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.phro.2022.02.007_b0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13014-019-1309-x","article-title":"Ablative radiation therapy for locally advanced pancreatic cancer: techniques and results","volume":"14","author":"Reyngold","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2022.02.007_b0045","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamaoncol.2021.0057","article-title":"Association of ablative radiation therapy with survival among patients with inoperable pancreatic cancer","volume":"7","author":"Reyngold","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.phro.2022.02.007_b0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13014-019-1275-3","article-title":"Online adaptive magnetic resonance guided radiotherapy for pancreatic cancer: state of the art, pearls and pitfalls","volume":"14","author":"Boldrini","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2022.02.007_b0055","article-title":"Ablative 5-fraction stereotactic magnetic resonance-guided radiation therapy (MRgRT) with on-table adaptive replanning and elective nodal irradiation for inoperable pancreas cancer","author":"Chuong","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.phro.2022.02.007_b0060","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/cam4.2100","article-title":"Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer","volume":"8","author":"Rudra","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.phro.2022.02.007_b0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13014-020-1482-y","article-title":"Accuracy of automatic deformable structure propagation for high-field MRI guided prostate radiotherapy","volume":"15","author":"Christiansen","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2022.02.007_b0070","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.ijrobp.2020.12.015","article-title":"Initial feasibility and clinical implementation of daily MR-guided adaptive head and neck cancer radiation therapy on a 1.5T MR-Linac system: prospective R-IDEAL 2a\/2b systematic clinical evaluation of technical innovation","volume":"109","author":"McDonald","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2022.02.007_b0075","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1016\/j.ijrobp.2011.12.073","article-title":"Characterization and management of interfractional anatomic changes for pancreatic cancer radiotherapy","volume":"83","author":"Liu","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2022.02.007_b0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.radonc.2019.01.030","article-title":"Modeling daily changes in organ-at-risk anatomy in a cohort of pancreatic cancer patients","volume":"134","author":"Magallon-Baro","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2022.02.007_b0085","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2019.01.020","article-title":"Pancreatic cancer treated with SBRT: effect of anatomical interfraction variations on dose to organs at risk","volume":"134","author":"Loi","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2022.02.007_b0090","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1002\/mp.14906","article-title":"Deep-learning-based image registration and automatic segmentation of organs-at-risk in cone-beam CT scans from high-dose radiation treatment of pancreatic cancer","volume":"48","author":"Han","year":"2021","journal-title":"Med Phys"},{"key":"10.1016\/j.phro.2022.02.007_b0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.phro.2021.07.006","article-title":"Feasibility of ablative stereotactic body radiation therapy of pancreas cancer patients on a 1.5 Tesla magnetic resonance-linac system using abdominal compression","volume":"19","author":"Tyagi","year":"2021","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.phro.2022.02.007_b0100","first-page":"54","article-title":"Adaptive radiotherapy: The Elekta Unity MR-linac concept","volume":"18","author":"Winkel","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.phro.2022.02.007_b0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fninf.2013.00039","article-title":"Explicit B-spline regularization in diffeomorphic image registration","volume":"7","author":"Tustison","year":"2013","journal-title":"Front Neuroinform"},{"key":"10.1016\/j.phro.2022.02.007_b0110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.phro.2020.03.002","article-title":"Quantification of accumulated dose and associated anatomical changes of esophagus using weekly Magnetic Resonance Imaging acquired during radiotherapy of locally advanced lung cancer","volume":"13","author":"Alam","year":"2020","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.phro.2022.02.007_b0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-3-030-00807-9_4","article-title":"Quantification of local metabolic tumor volume changes by registering blended PET-CT images for prediction of pathologic tumor response","volume":"11076","author":"Alam","year":"2018","journal-title":"Lect Note Comp Sci"},{"key":"10.1016\/j.phro.2022.02.007_b0120","series-title":"The ITK software guide","author":"Ibanez","year":"2005"},{"key":"10.1016\/j.phro.2022.02.007_b0125","doi-asserted-by":"crossref","first-page":"145020","DOI":"10.1088\/1361-6560\/aacd22","article-title":"Quantifying local tumor morphological changes with Jacobian map for prediction of pathologic tumor response to chemo-radiotherapy in locally advanced esophageal cancer","volume":"63","author":"Riyahi","year":"2018","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.phro.2022.02.007_b0130","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ijrobp.2021.01.007","article-title":"Early prediction of acute esophagitis for adaptive radiotherapy","volume":"110","author":"Alam","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2022.02.007_b0135","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.semradonc.2019.02.002","article-title":"Deformable Registration for dose accumulation","volume":"29","author":"Chetty","year":"2019","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.phro.2022.02.007_b0140","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/10543400701329422","article-title":"Agreement between methods of measurement with multiple observations per individual","volume":"17","author":"Bland","year":"2007","journal-title":"J Biopharm Stat"},{"key":"10.1016\/j.phro.2022.02.007_b0145","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.prro.2020.09.005","article-title":"Ablative 5-fraction stereotactic magnetic resonance-guided radiation therapy with on-table adaptive replanning and elective nodal irradiation for inoperable pancreas cancer","volume":"11","author":"Chuong","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.phro.2022.02.007_b0150","doi-asserted-by":"crossref","first-page":"100506","DOI":"10.1016\/j.adro.2020.06.010","article-title":"Ablative Five-fraction stereotactic body radiation therapy for inoperable pancreatic cancer using online MR-guided adaptation","volume":"6","author":"Hassanzadeh","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.phro.2022.02.007_b0155","doi-asserted-by":"crossref","unstructured":"Brock KK, Mutic S, McNutt TR, Li H, Kessler ML. Use of image registration and fusion algorithms and techniques in radiotherapy: Report of the AAPM Radiation Therapy Committee Task Group No. 132. Med Phys. 2017;44:e43-e76.","DOI":"10.1002\/mp.12256"},{"key":"10.1016\/j.phro.2022.02.007_b0160","doi-asserted-by":"crossref","first-page":"e908","DOI":"10.1002\/mp.13162","article-title":"Patient-specific validation of deformable image registration in radiation therapy: overview and caveats","volume":"45","author":"Paganelli","year":"2018","journal-title":"Med Phys"},{"key":"10.1016\/j.phro.2022.02.007_b0165","series-title":"Morphometry. Human brain function","author":"Ashburner","year":"2004"},{"key":"10.1016\/j.phro.2022.02.007_b0170","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11548-014-1128-3","article-title":"Morphometry-based measurements of the structural response to whole-brain radiation","volume":"10","author":"Fuentes","year":"2015","journal-title":"Int J Comput Assist Radiol Surg"},{"key":"10.1016\/j.phro.2022.02.007_b0175","first-page":"6914","article-title":"Quantitative growth measurement of lesions in hepatic interval CT exams","author":"Sarkar","year":"2008","journal-title":"Med Imag"},{"key":"10.1016\/j.phro.2022.02.007_b0180","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.radonc.2017.07.028","article-title":"Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer","volume":"125","author":"Bohoudi","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2022.02.007_b0185","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/acm2.12577","article-title":"Intrafraction tumor motion during deep inspiration breath hold pancreatic cancer treatment","volume":"20","author":"Zeng","year":"2019","journal-title":"J Appl Clin Med Phys"}],"container-title":["Physics and Imaging in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631622000112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631622000112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:13:49Z","timestamp":1762503229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405631622000112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":37,"alternative-id":["S2405631622000112"],"URL":"https:\/\/doi.org\/10.1016\/j.phro.2022.02.007","relation":{},"ISSN":["2405-6316"],"issn-type":[{"value":"2405-6316","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inter- and intrafraction motion assessment and accumulated dose quantification of upper gastrointestinal organs during magnetic resonance-guided ablative radiation therapy of pancreas patients","name":"articletitle","label":"Article Title"},{"value":"Physics and Imaging in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phro.2022.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}]}}